Dirk Thye is CEO AND CHIEF MEDICAL OFFICER of Cortexyme, Inc.. Currently has a direct ownership of 843,941 shares of CRTX, which is worth approximately $1.09 Million. The most recent transaction as insider was on Aug 30, 2024, when has been sold 77,000 shares (Common Stock) at a price of $0.7 per share, resulting in proceeds of $53,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 844K
22.41% 3M change
88.0% 12M change
Total Value Held $1.09 Million

Dirk Thye Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 30 2024
BUY
Open market or private purchase
$53,900 $0.7 p/Share
77,000 Added 8.36%
843,941 Common Stock
Aug 29 2024
BUY
Open market or private purchase
$53,474 $0.69 p/Share
77,500 Added 9.18%
766,941 Common Stock
Jan 16 2024
BUY
Exercise of conversion of derivative security
$180,397 $0.75 p/Share
240,530 Added 25.86%
689,441 Common Stock
Aug 10 2023
BUY
Open market or private purchase
$110,880 $1.26 p/Share
88,000 Added 16.39%
448,911 Common Stock
Aug 08 2023
BUY
Open market or private purchase
$99,200 $1.24 p/Share
80,000 Added 18.14%
360,911 Common Stock
May 19 2022
BUY
Grant, award, or other acquisition
-
64,589 Added 50.0%
64,589 Common Stock
DT

Dirk Thye

CEO AND CHIEF MEDICAL OFFICER
South San Francisco, CA

Track Institutional and Insider Activities on CRTX

Follow Cortexyme, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRTX shares.

Notify only if

Insider Trading

Get notified when an Cortexyme, Inc. insider buys or sells CRTX shares.

Notify only if

News

Receive news related to Cortexyme, Inc.

Track Activities on CRTX